The Mesothelioma Center News - Page 2
Colombia Ban of Asbestos Sets Example for US to Follow
- by Tim Povtak
- Asbestos Exposure & Bans
- Jun 19, 2019
Linda Reinstein was not surprised by the news last week that Colombia had joined the growing list of more than 60 countries to legislate a ban of asbestos. She…
Read More
Study Begins to Develop Breath Test for Mesothelioma Early Detection
- by Tim Povtak
- Research & Clinical Trials
- Jun 18, 2019
As an occupational medicine specialist for more than 30 years, Dr. Michael Harbut has spent much of his career combating asbestos-related disease. Rarely has he felt this energized. Harbut is…
Read More
Long-Term 9/11 Funding Bill Moves Closer to Reality
- by Tim Povtak
- Asbestos Exposure & Bans
- Jun 13, 2019
The House Judiciary Committee passed the Never Forget the Heroes bill Wednesday that will extend the 9/11 Victim Compensation Fund until 2090. The bill would ensure all victims of the…
Read More
Study Combines PD-1 and CAR-T Immunotherapy to Treat Mesothelioma
- by Suzanne Dixon
- Research & Clinical Trials
- Jun 13, 2019
At the 2019 American Society of Clinical Oncology annual meeting, Dr. Prasad Adusumilli from Memorial Sloan Kettering Cancer Center shared exciting new results from his study on combination immunotherapy…
Read More
Mesothelioma Treatment Guidelines Not Followed Often Enough
- by Tim Povtak
- Treatment & Doctors
- Jun 12, 2019
Too many patients with pleural mesothelioma are going without treatment recommended by National Comprehensive Cancer Network guidelines, according to a recent study at Cedars-Sinai Medical Center in Los Angeles.
Read More
Claire’s Recalls JoJo Siwa Makeup over Asbestos Contamination
- by Matt Mauney
- Asbestos Exposure & Bans
- Jun 7, 2019
For the second time in three months, Claire’s stores issued a voluntary recall over concerns of asbestos contamination in its makeup products marketed to young girls, the U.S. Food and…
Read More
Study Finds Modest Reality of Immunotherapy for Cancer
- by Tim Povtak
- Research & Clinical Trials
- Jun 6, 2019
Less than 13% of cancer patients who receive checkpoint inhibitor drugs such as Keytruda (pembrolizumab) and Opdivo (nivolumab) actually benefit from the much-heralded form of immunotherapy, new research shows.
Read More
Johnson & Johnson Hit with $325M Verdict in Talc-Mesothelioma Case
- by Tim Povtak
- Legislation & Litigation
- Jun 3, 2019
A state jury in New York ordered Johnson & Johnson to pay $300 million in punitive damages to Donna Olson and her husband who claim its talcum powder caused her…
Read More
FDA Approves First New Treatment for Mesothelioma in 15 Years
- by Matt Mauney
- Treatment & Doctors
- May 24, 2019
The U.S. Food & Drug Administration on Thursday approved Tumor Treating Fields, a therapy involving electric currents that disrupt cancer cell division and inhibit tumor growth, for the first-line treatment…
Read More
Quality of Life Still Good with HIPEC Surgery for Peritoneal Mesothelioma
- by Tim Povtak
- Research & Clinical Trials
- May 22, 2019
Surgical oncologist Dr. Edward Levine was not surprised by the encouraging results of the recent study measuring quality-of-life issues following aggressive treatment for patients with peritoneal mesothelioma. He has…
Read More
